despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.
.
. is putting his shoulder into legislation that would help others access the same sort of care he received when he suffered a stroke midway through his playing career.
. 
. 
.